Results from an umbrella review of observational studies showed highly suggestive or suggestive evidence for HIV and the presence of several physical health outcomes.
Overall prevalence of chronic hypertension 0.63%; rate more than twofold higher for black women.
Guidelines address lifestyle recommendations, individualized BP targets, SGLT2 inhibitor, GLP1-RA treatment.
Lower CD4 count, nonsuppressed viral load linked to higher risk for sudden cardiac death in HIV with heart failure.
A fixed-dose combination pill may be an effective component of a preventive strategy to reduce cardiovascular disease.
Investigators studied the effects of midlife high or increasing blood pressure on late-life brain structure.
Risk for readmissions and adverse effects higher, no long-term benefit for BP control or cardiac risk.
Investigators analyzed the relationship between HIV, hepatitis C virus, and peripheral artery disease in women.
Findings seen among long-term nursing home residents with, without cognitive impairment.
This scientific statement released by the American Heart Association covers noninvasive assessment of limb perfusion, including limitations associated with currently available technology.
In a large population-based study, individuals with sustained hypertension in midlife to late life had a 49% increased risk of subsequent dementia compared with those who remained normotensive.
Considerable proportion of increased CHF, IHD, and stroke risk mediated by NSAID use.
This updated meta-analysis supports a target BP of less than 130/80 for secondary stroke prevention.
Lifestyle management should be priority for prevention of ASCVD, T2DM in patients at metabolic risk.
Applying new hypertension guidelines to pregnant women increased prevalence of high blood pressure.
Researchers sought to compare the quality of care provided by advanced practice providers with cardiologists for patients in a post-percutaneous coronary intervention setting.
Women with type 1, type 2 diabetes have greater excess risk for heart failure vs men.
Researchers sought to investigate the association between proton pump inhibitor use and cause-specific mortality in US Veterans.
A history of mild liver disease is associated with a higher risk for bleeding during anticoagulation therapy but does not change the relative efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation.
Young adult LDL ≥100 mg/dL tied to 64% increased risk for CHD, independent of later levels.